Effects of beta-adrenergic blockade on diurnal variability of blood pressure and plasma noradrenaline levels. 1977

P W de Leeuw, and H E Falke, and T L Kho, and R Vandongen, and A Wester, and W H Birkenhäger

The effect of propranolol on diurnal variability of BP and plasma noradrenaline levels was assessed in 15 patients with uncomplicated essential hypertension. While total variability and average noradrenaline level remained unaltered, the pressor range (difference between basal and maximum BP readings) was reduced in most patients. An inverse relationship was observed between changes in pressor range and noradrenaline.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

P W de Leeuw, and H E Falke, and T L Kho, and R Vandongen, and A Wester, and W H Birkenhäger
August 1976, Clinical pharmacology and therapeutics,
P W de Leeuw, and H E Falke, and T L Kho, and R Vandongen, and A Wester, and W H Birkenhäger
November 1978, The Journal of physiology,
P W de Leeuw, and H E Falke, and T L Kho, and R Vandongen, and A Wester, and W H Birkenhäger
March 1966, British journal of pharmacology and chemotherapy,
P W de Leeuw, and H E Falke, and T L Kho, and R Vandongen, and A Wester, and W H Birkenhäger
July 1979, European journal of clinical pharmacology,
P W de Leeuw, and H E Falke, and T L Kho, and R Vandongen, and A Wester, and W H Birkenhäger
January 1995, Clinical and experimental hypertension (New York, N.Y. : 1993),
P W de Leeuw, and H E Falke, and T L Kho, and R Vandongen, and A Wester, and W H Birkenhäger
January 1968, Archives internationales de pharmacodynamie et de therapie,
P W de Leeuw, and H E Falke, and T L Kho, and R Vandongen, and A Wester, and W H Birkenhäger
April 1974, Nature,
P W de Leeuw, and H E Falke, and T L Kho, and R Vandongen, and A Wester, and W H Birkenhäger
August 1995, International journal of sports medicine,
P W de Leeuw, and H E Falke, and T L Kho, and R Vandongen, and A Wester, and W H Birkenhäger
January 1993, Polski tygodnik lekarski (Warsaw, Poland : 1960),
P W de Leeuw, and H E Falke, and T L Kho, and R Vandongen, and A Wester, and W H Birkenhäger
January 1975, Clinical and experimental pharmacology & physiology,
Copied contents to your clipboard!